Literature DB >> 22288321

The discontinuation rate and reasons for discontinuation of implanon at the family planning clinic of University of Nigeria Teaching Hospital (UNTH) Enugu, Nigeria.

H U Ezegwui1, L C Ikeako, C I C Ishiekwene, T C Oguanua.   

Abstract

BACKGROUND: In spite of the popularity and effectiveness of the Implanon among family planning clients at University of Nigeria Teaching Hospital (U.N.T.H) Enugu Nigeria, some users discontinued its use for a variety of reasons.
OBJECTIVE: To determine the Implanon discontinuation rate and reasons for discontinuation among women attending University of Nigeria Teaching Hospital (U.N.T.H) Enugu, Nigeria.
MATERIALS AND METHODS: This retrospective survey comprised 63 women who had Implanon implant discontinued out of 295 women who had Implanon inserted between 2006 and 2008. The records of patient at the Family Planning Clinic of the hospital were analysed. The main outcome measured was Implanon discontinuation.
RESULTS: Sixty-three (21.4%) of women who had Implanon implant during this period discontinued its use. The discontinuation rate within six months of use was 3.0%, within one year, 8.1% and within two years, 19.3%. Thirty-six (12.2%) discontinued Implanon because of side effects while 27 (9.2%) discontinued because of desire for pregnancy. Fifteen (41.7%) out of the 36 women who discontinued because of side effects had menstrual abnormalities. Headache and dizziness accounts for the majority (38.1%) of non-menstrual reasons for discontinuation. There was no pregnancy recorded. All those who discontinued Implanon within six months ofuse were because of side effects.
CONCLUSION: The discontinuation of Implanon before its expiration is low once the users are adequately counseled. Implanon is well accepted among our clients but cost affect its wider use.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22288321

Source DB:  PubMed          Journal:  Niger J Med        ISSN: 1115-2613


  10 in total

1.  Determinants of Implanon Discontinuation among Women Who Use Implanon at Bahir Dar Town Health Institutions, Northwest Ethiopia, 2019: A Case-Control Study.

Authors:  Tsegaw Yehuala; Ergoye Melese; Kassawmar Angaw Bogale; Baye Dagnew
Journal:  Evid Based Complement Alternat Med       Date:  2020-09-24       Impact factor: 2.629

2.  Contraceptive discontinuation and switching among couples receiving integrated HIV and family planning services in Lusaka, Zambia.

Authors:  Lisa Haddad; Kristin M Wall; Bellington Vwalika; Naw Htee Khu; Ilene Brill; William Kilembe; Rob Stephenson; Elwyn Chomba; Cheswa Vwalika; Amanda Tichacek; Susan Allen
Journal:  AIDS       Date:  2013-10       Impact factor: 4.177

3.  Knowledge and attitudes towards use of long acting reversible contraceptives among women of reproductive age in Lubaga division, Kampala district, Uganda.

Authors:  Ronald Anguzu; Raymond Tweheyo; Juliet N Sekandi; Vivian Zalwango; Christine Muhumuza; Suzan Tusiime; David Serwadda
Journal:  BMC Res Notes       Date:  2014-03-17

4.  Factors associated with early long-acting reversible contraceptives discontinuation in Ethiopia: evidence from the 2016 Ethiopian demographic and health survey.

Authors:  Gedefaw Abeje Fekadu; Akinyinka O Omigbodun; Olumuyiwa A Roberts; Alemayehu Worku Yalew
Journal:  Arch Public Health       Date:  2020-07-01

Review 5.  There might be blood: a scoping review on women's responses to contraceptive-induced menstrual bleeding changes.

Authors:  Chelsea B Polis; Rubina Hussain; Amanda Berry
Journal:  Reprod Health       Date:  2018-06-26       Impact factor: 3.223

6.  The prevalence of Implanon discontinuation and associated factors among Ethiopian women: A systematic review and meta-analysis.

Authors:  Aklilu Habte; Aiggan Tamene; Demelash Woldeyohannes; Biruk Bogale; Dejene Ermias; Fitsum Endale; Addisalem Gizachew; Merertu Wondimu; Dawit Sulamo
Journal:  Womens Health (Lond)       Date:  2022 Jan-Dec

7.  Factors associated with discontinuation among long-acting reversible contraceptive users: a multisite prospective cohort study in urban public health facilities in Ethiopia.

Authors:  Getasew Sisay Mihretie; Solomon Mekonnen Abebe; Yeshiwas Abebaw; Leta Gedefa; Tadesse Gure; Birtukan Asmare Alemayehu; Demisew Amenu; Daniel Tadesse; Girma Abraham Fanta; Ferid Abbas Abubeker; Awol Yemane; Amanuel Desta G/Michael; Alula M Teklu; Mengistu Hailemariam Damtew; Bisrat Girma
Journal:  BMJ Open       Date:  2022-08-02       Impact factor: 3.006

8.  Evidence of patients' challenges and barriers related to usage of Implanon®: scoping review protocol.

Authors:  Shimona Prosad; Tivani P Mashamba-Thompson; Elizabeth Ojewole
Journal:  Syst Rev       Date:  2018-10-12

9.  Incidence and determinants of Implanon discontinuation: Findings from a prospective cohort study in three health zones in Kinshasa, DRC.

Authors:  P Z Akilimali; Hernandez J; Anglewicz P; Kayembe K P; Bertrand J
Journal:  PLoS One       Date:  2020-05-11       Impact factor: 3.240

10.  Survival time to Implanon discontinuation and its predictors among a cohort of Implanon users who enrolled in public hospitals of southern Ethiopia, 2021: a retrospective cohort study.

Authors:  Aklilu Habte; Merertu Wondimu; Hanan Abdulkadir
Journal:  Arch Public Health       Date:  2022-03-23
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.